ATNM
Actinium Pharmaceuticals, IncstockNYSEAMERICAN
At CloseNov 17, 2026 3:59:50 PM EST
1.33USD-10.738%(-0.16)553,295
After-hoursNov 17, 2026 4:10:30 PM EST
1.35USD+1.504%(+0.02)
ATNM Financials
In Q3 FY 2026 (ended ), Actinium Pharmaceuticals, Inc (ATNM) reported revenue of $0, net income of −$5.84M, operating cash flow of −$7.02M, and assets of $32.47M (filed ).
Loading business breakdowns…
